NHG-Standaard
M82
3.2
september 2013
januari 2025
W/X/Y. Zwangerschap / anticonceptie / geslachtsorganen man en vrouw
Richtlijnen diagnostiek
Naar Volledige tekst ›Risicoschatting
Naar Volledige tekst ›Anamnese
Naar Volledige tekst ›Lichamelijk onderzoek
Naar Volledige tekst ›Aanvullend onderzoek
Naar Volledige tekst ›Evaluatie
Naar Volledige tekst ›Richtlijnen beleid
Naar Volledige tekst ›Voorlichting
Naar Volledige tekst ›Beleid op basis van klinisch beeld
Naar Volledige tekst ›Beleid per soa
Naar Volledige tekst ›Seks- en prikaccidenten
Naar Volledige tekst ›Inleiding
Naar Samenvatting ›Scope
Naar Samenvatting ›Buiten de scope
Naar Samenvatting ›Samenwerking en afstemming
Naar Samenvatting ›Achtergronden
Naar Samenvatting ›Begrippen
Naar Samenvatting ›Aids
Naar Samenvatting ›Centrum Seksuele Gezondheid
Naar Samenvatting ›Endemisch gebied
Naar Samenvatting ›Soa-endemisch gebied
Naar Samenvatting ›Hiv-endemisch gebied
Naar Samenvatting ›Hepatitis B-endemisch gebied
Naar Samenvatting ›Hiv-indicatorziekten
Naar Samenvatting ›Lymfogranuloma venereum (LGV)
Naar Samenvatting ›NAAT/PCR
Naar Samenvatting ›Point-of-care-test
Naar Samenvatting ›Windowfase
Naar Samenvatting ›Zelftest
Naar Samenvatting ›Zelfafnametest
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Soa-consulten bij de huisarts
Naar Samenvatting ›Gelijktijdig voorkomen van meerdere soa’s
Naar Samenvatting ›Chlamydia trachomatis
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Beloop
Naar Samenvatting ›Neisseria gonorrhoeae
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Beloop
Naar Samenvatting ›Syfilis (treponema pallidum)
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Hepatitis B-virus
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Beloop
Naar Samenvatting ›Hepatitis C-virus
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Hiv-indicatorziekten
Naar Samenvatting ›Beloop
Naar Samenvatting ›Trichomonas vaginalis
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Beloop
Naar Samenvatting ›Herpes genitalis (herpessimplexvirus)
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Beloop
Naar Samenvatting ›Genitale wratten (humaan papillomavirus)
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Beloop
Naar Samenvatting ›Schaamluis
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Mycoplasma genitalium
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Transmissie
Naar Samenvatting ›Symptomatologie
Naar Samenvatting ›Beloop
Naar Samenvatting ›Richtlijnen diagnostiek
Naar Samenvatting ›Risicoschatting
Naar Samenvatting ›Risicogroepen en risicogedrag
Naar Samenvatting ›Vragen bij de risicoschatting
Naar Samenvatting ›Anamnese
Naar Samenvatting ›Bij alle patiënten met klachten
Naar Samenvatting ›Bij blaasjes
Naar Samenvatting ›Bij wratjes
Naar Samenvatting ›Bij mogelijke proctitis
Naar Samenvatting ›Bij vaginale klachten
Naar Samenvatting ›Bij mannen met urethritis en/of mogelijke epididymitis
Naar Samenvatting ›Lichamelijk onderzoek
Naar Samenvatting ›Bij patiënten zonder klachten
Naar Samenvatting ›Bij patiënten met klachten
Naar Samenvatting ›Bij blaasjes
Naar Samenvatting ›Bij wratjes
Naar Samenvatting ›Bij mogelijke proctitis
Naar Samenvatting ›Bij vaginale klachten
Naar Samenvatting ›Bij mannen met urethritis en/of mogelijke epididymitis
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Algemeen
Naar Samenvatting ›Diagnostische tests
Naar Samenvatting ›Bij patiënten zonder klachten
Naar Samenvatting ›Patiënten zonder klachten, behorend tot een hoogrisicogroep
Naar Samenvatting ›Patiënten zonder klachten, niet behorend tot een hoogrisicogroep
Naar Samenvatting ›Bij patiënten met klachten
Naar Samenvatting ›Patiënten met klachten behorend tot een hoogrisicogroep
Naar Samenvatting ›Bij patiënten met klachten niet behorend tot een hoogrisicogroep
Naar Samenvatting ›Bij blaasjes
Naar Samenvatting ›Bij wratjes
Naar Samenvatting ›Bij mogelijke proctitis
Naar Samenvatting ›Bij vaginale klachten
Naar Samenvatting ›Intermenstrueel en postcoïtaal bloedverlies
Naar Samenvatting ›Bij mannen met urethritis en/of mogelijke epididymitis
Naar Samenvatting ›Bij hard en (pijnloos) ulcus (vermoeden syfilis)
Naar Samenvatting ›Bij vermoeden van orale gonorroe
Naar Samenvatting ›Diagnostiek per soa
Naar Samenvatting ›Chlamydia trachomatis
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Neisseria gonorrhoeae
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Syfilis (treponema pallidum)
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Hepatitis B
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Trichomonas vaginalis
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Herpes genitalis (herpessimplexvirus)
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Genitale wratten (humaan papillomavirus)
Naar Samenvatting ›Schaamluis
Naar Samenvatting ›Mycoplasma genitalium
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Richtlijnen beleid
Naar Samenvatting ›Voorlichting
Naar Samenvatting ›Alle patiënten
Naar Samenvatting ›Patiënten met aangetoonde soa
Naar Samenvatting ›Thuisarts
Naar Samenvatting ›Patiënten met verhoogd risico op soa
Naar Samenvatting ›Veilige seks
Naar Samenvatting ›Pre-expositieprofylaxe (PrEP)
Naar Samenvatting ›Thuisarts
Naar Samenvatting ›Beleid op basis van klinisch beeld
Naar Samenvatting ›Urethritis
Naar Samenvatting ›Epididymitis (vermoedelijk op basis van een soa)
Naar Samenvatting ›Proctitis (vermoedelijk op basis van een soa)
Naar Samenvatting ›Beleid per soa
Naar Samenvatting ›Chlamydia trachomatis
Naar Samenvatting ›Neisseria gonorrhoeae
Naar Samenvatting ›Syfilis (treponema pallidum)
Naar Samenvatting ›Controle
Naar Samenvatting ›Hepatitis B-virus
Naar Samenvatting ›Partnerwaarschuwing
Naar Samenvatting ›Trichomonas vaginalis
Naar Samenvatting ›Herpes genitalis (herpessimplexvirus)
Naar Samenvatting ›Controle
Naar Samenvatting ›Genitale wratten (humaan papillomavirus)
Naar Samenvatting ›Controle
Naar Samenvatting ›Schaamluis
Naar Samenvatting ›Mycoplasma genitalium
Naar Samenvatting ›Controle
Naar Samenvatting ›Seks- en prikaccidenten
Naar Samenvatting ›Referenties
- Van der Vleugel Y, Mouhebati T. Hiv bij migranten. Huisarts Wet 2019;62. (geraadpleegd november 2021) Ga naar bron: Van der Vleugel Y, Mouhebati T. Hiv bij migranten. Huisarts Wet 2019;62. (geraadpleegd november 2021)
- UNAIDS. Joint United Nations Programme on HIV/AIDS. UNAIDS DATA 2020. (geraadpleegd november 2021) Ga naar bron: UNAIDS. Joint United Nations Programme on HIV/AIDS. UNAIDS DATA 2020. (geraadpleegd november 2021)
- UNAIDS. Joint United Nations Programme on HIV/AIDS. Global aids monitoring 2019: Ukraine. (geraadpleegd november 2021) Ga naar bron: UNAIDS. Joint United Nations Programme on HIV/AIDS. Global aids monitoring 2019: Ukraine. (geraadpleegd november 2021)
- LCI. Richtlijn Hepatitis B (2012).
- RIVM. Sexually transmitted infections in the Netherlands in 2019. RIVM, Bilthoven (2020). Ga naar bron: RIVM. Sexually transmitted infections in the Netherlands in 2019. RIVM, Bilthoven (2020).
- Van den Broek IV, Verheij RA, Van Dijk CE, Koedijk FD, Van der Sande MA, Van Bergen JE. Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centers. BMC Fam Pract 2010;11:39.
- Van Bergen JE, Kerssens JJ, Schellevis FG, Sandfort TG, Coenen TJ, Bindels PJ. Prevalence of STI related consultations in general practice: results from the second Dutch National Survey of General Practice. Br J Gen Pract 2006;56:104-9.
- Van Bergen JE, Kerssens JJ, Schellevis FG, Sandfort TG, Coenen TT, Bindels PJ. Sexually transmitted infection health-care seeking behaviour in the Netherlands: general practitioner attends to the majority of sexually transmitted infection consultations. Int J STD AIDS 2007;18:374-9.
- Heijne JCM, Van den Broek IVF, Bruisten SM, Van Bergen JEA, De Graaf H, Van Benthem BHB. National prevalence estimates of chlamydia and gonorrhoea in the Netherlands. Sex Transm Infect 2019 ;95:53-59.
- Althaus CL, Heijne JC, Low N. Towards more robust estimates of the transmissibility of Chlamydia trachomatis. Sex Transm Dis 2012;39:402-4.
- Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:185-92.
- Van Liere GAFS, Hoebe CJPA, Dirks JA, Wolffs PF, Dukers-Muijrers NHTM. Spontaneous clearance of urogenital, anorectal and oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women, MSM and heterosexual men visiting the STI clinic: a prospective cohort study. Sex Transm Infect 2019;95:505-10.
- Dukers-Muijrers NHTM, Wolffs PFG, De Vries H, Götz HM, Heijman T, Bruisten S, et al. Treatment effectiveness of azithromycin and doxycycline in uncomplicated rectal and vaginal chlamydia trachomatis infections in Women: a Multicenter Observational Study (FemCure). Clin Infect Dis 2019;69:1946-54.
- Chandra NL, Broad C, Folkard K, Town K, Harding-Esch EM, Woodhall SC, et al. Detection of chlamydia trachomatis in rectal specimens in women and its association with anal intercourse: a systematic review and meta-analysis. Sex Transm Infect 2018;94:320-26.
- Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, et al. Extragenital infections caused by chlamydia trachomatis and neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol 2016:1-17.
- Golden MR, Schillinger JA, Markowitz L, St Louis ME. Duration of untreated genital infections with chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000;27:329-37.
- Morre SA, Van den Brule AJ, Rozendaal L, Boeke AJ, Voorhorst FJ, De Blok S, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002;13 Suppl 2:12-8.
- Geisler WM. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010;201 Suppl 2:S104-S113.
- Dukers-Muijrers NHTM, Wolffs P, Lucchesi M, Götz HM, De Vries H, Schim van der Loeff M, Bruisten SM, Hoebe CJPA. Oropharyngeal Chlamydia trachomatis in women; spontaneous clearance and cure after treatment (FemCure). Sex Transm Infect 2021;97:147-151.
- Evers JL. Female subfertility. Lancet 2002;360:151-9.
- Snick HK, Snick TS, Evers JL, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod 1997;12:1582-8.
- Den Heijer CDJ, Hoebe CJPA, Driessen JHM, Wolffs P, Van den Broek IVF, Hoenderboom BM, et al. Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility: a retrospective cohort study among primary care patients. Clin Infect Dis 2019;69:1517-25.
- Hoenderboom BM, Van Benthem BHB, Van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA et al. Relation between chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a dutch cohort of women previously tested for chlamydia in a chlamydia screening trial. Sex Transm Infect 2019;95:300-6.
- Hoenderboom BM, Van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, De Vries HJC, et al. Pregnancies and time to pregnancy in women with and without a previous chlamydia trachomatis Infection. Sex Transm Dis 2020;47:739-47.
- Price MJ, Ades AE, Soldan K, Welton NJ, Macleod J, Simms I, et al. The natural history of chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. Health Technol Assess 2016;20:1-250.
- Land JA, van Bergen JE, Morre SA, Postma MJ. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update 2010;16:189-204.
- Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. American journal of obstetrics
- Bakken IJ, Skjeldestad FE, Lydersen S, Nordbo SA. Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sexually transmitted diseases 2007;34:739-43.
- Davies B, Turner KME, Frølund M, Ward H, May MT, Rasmussen S, et al. Danish Chlamydia Study Group. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis 2016;16:1057-1064.
- Chayachinda C, Rekhawasin T. Reproductive outcomes of patients being hospitalised with pelvic inflammatory disease. J Obstet Gynaecol 2017;37:228-32.
- Trent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis 2011;38:879-81.
- Low N, Egger M, Sterne JA, Harbord RM, Ibrahim F, Lindblom B, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the uppsala women’s cohort study. Sex Transm Infect 2006;82:212-8.
- Reekie J, Donovan B, Guy R, Hocking JS, Kaldor JM, Mak DB, et al. Chlamydia and reproductive health outcome investigators; risk of pelvic inflammatory disease in relation to chlamydia and gonorrhea testing, repeat testing, and positivity: a population-based cohort study. Clin Infect Dis 2018 18;66:437-43.
- Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Sparling PF, Mardh PA, editors. Sexually transmitted diseases. New York: McGraw-Hill, 1999: 407-22.
- Mazzoli S, Cai T, Addonisio P, Bechi A, Mondaini N, Bartoletti R. Chlamydia trachomatis infection is related to poor semen quality in young prostatitis patients. Eur Urol 2010;57:708-14.
- Baud D, Regan L, Greub G. Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes. Curr Opin Infect Dis 2008;21:70-6.
- Blas MM, Canchihuaman FA, Alva IE, Hawes SE. Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State. Sex Transm Infect 2007;83:314-8.
- Rours GI, Duijts L, Moll HA, Arends LR, De Groot R, Jaddoe VW, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol 2011;26:493-502.
- Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents 2007;30:213-21.
- Rours IG, Hammerschlag MR, Ott A, De Faber TJ, Verbrugh HA, De Groot R, et al. Chlamydia trachomatis as a cause of neonatal conjunctivitis in Dutch infants. Pediatrics 2008;121:e321-e326.
- Lycke E, Lowhagen GB, Hallhagen G, Johannisson G, Ramstedt K. The risk of transmission of genital Chlamydia trachomatis infections is less than that of Neisseria gonorrhoeae infection. Sex Transm Dis 1980;7:6-10.
- Lin JS, Donegan SP, Heeren TC, Greenberg M, Flaherty EE, Haivanis R, et al. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J Infect Dis 1998;178:1707-12.
- Hook EW, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Mardh PA, editors. Sexually transmitted diseases. New York: McGraw-Hill, 1999: 451-63.
- Baas M, Beers E, Van Dam AP, Van Bergen JE. Who cares for syphilis? A cross-sectional study on diagnosis and treatment of syphilis by GPs in Amsterdam, the Netherlands. BJGP Open 2020;4:1-11.
- Garnett GP, Aral SO, Hoyle DV, Cates W, Jr., Anderson RM. The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis 1997;24:185-200.
- Koedijk FDH, Van der Sande MAB, Hahné SJM. Aangifte acute hepatitis B in 2010. Infectieziekten Bulletin (2011). RIVM. Ga naar bron: Koedijk FDH, Van der Sande MAB, Hahné SJM. Aangifte acute hepatitis B in 2010. Infectieziekten Bulletin (2011). RIVM.
- LCI. Protocol Hepatitis B (2004). Ga naar bron: LCI. Protocol Hepatitis B (2004).
- Van Sighem AI, Wit FWNM, Boyd A, Smit C, Matser A, Van der Valk M. Monitoring Report 2021. Human Immunodeficiency Virus (HIV) Infection in the Netherlands. Amsterdam: Stichting HIV Monitoring, 2021.
- Van Sighem AI, Boender TS, Wit FWNM, Smit C, Matser A, Reiss P. Monitoring Report 2018. Human Immunodeficiency Virus (HIV) Infection in the Netherlands. Amsterdam: Stichting HIV Monitoring, 2018.
- UNAIDS. Joint United Nations Programme on HIV/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic (2014). (geraadpleegd december 2021) Ga naar bron: UNAIDS. Joint United Nations Programme on HIV/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic (2014). (geraadpleegd december 2021)
- Van Bergen J, Prins JM. De kans op hiv-transmissie per seksueel contact: wat weten we (niet)? (2008). Soa Aids Nederland.
- Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008;8:553-63.
- Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. PARTNER Study Group. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019;393:2428-38.
- UNAIDS. Joint United Nations Programme on HIV/AIDS. Voluntary medical male circumcision (2016). (geraadpleegd december 2021) Ga naar bron: UNAIDS. Joint United Nations Programme on HIV/AIDS. Voluntary medical male circumcision (2016). (geraadpleegd december 2021)
- Van Bergen J, Fennema H. Hiv en syfilis: een synergie met slechte uitkomst. SOA Bull 2002;23:20-2.
- Sheffield JS, Wendel GD, Jr., McIntire DD, Norgard MV. Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract. J Infect Dis 2007;196:1509-16.
- Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis 2008;47:258-65.
- Hilber AM, Francis SC, Chersich M, Scott P, Redmond S, Bender N, et al. Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS One 2010;5:e9119.
- Mavedzenge SN, Pol BV, Cheng H, Montgomery ET, Blanchard K, De Bruyn G, et al. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis 2010;37:460-6.
- Tuomala RE, O’Driscoll PT, Bremer JW, Jennings C, Xu C, Read JS, et al. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 2003;187:375-84.
- Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001;183:1017-22.
- LCI. Richtlijn hivinfectie. RIVM (2015). (geraadpleegd maart 2022) Ga naar bron: LCI. Richtlijn hivinfectie. RIVM (2015). (geraadpleegd maart 2022)
- HIV in Europe Initiative. HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings. Copenhagen: Copenhagen University, 2012.
- Joore IK, Op de Coul ELM, Bom BCJ, Van Sighem AI, Geerlings SE, Prins JM, et al. Proactiever testen op hiv is nodig. Huisarts Wet 2017;60(1):24-6 (geraadpleegd juni 2021) Ga naar bron: Joore IK, Op de Coul ELM, Bom BCJ, Van Sighem AI, Geerlings SE, Prins JM, et al. Proactiever testen op hiv is nodig. Huisarts Wet 2017;60(1):24-6 (geraadpleegd juni 2021)
- Gueler A, Moser A, Calmy A, Günthard HF, Bernasconi E, Furrer H, et al. Swiss HIV Cohort Study, Swiss National Cohort. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS 2017;31:427-36.
- Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV Infection, 2000-2016. JAMA Netw Open 2020;3:e207954.
- Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997;24:353-60.
- Kigozi GG, Brahmbhatt H, Wabwire-Mangen F, Wawer MJ, Serwadda D, Sewankambo N, et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2003;189:1398-400.
- Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
- Gülmezoglu AM, Azhar M. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev 2011;CD000220.
- Drake S, Taylor S, Brown D, Pillay D. Improving the care of patients with genital herpes. BMJ 2000;321:619-23.
- Roest R, Van der Meijden WI. Soa bulletin november 1999. Jubileumnummer.
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
- Winer RL, Koutsky L. Genital human papillomavirus infection in sexually transmitted diseases 4th revised edition. In: Sexually Transmitted Diseases. 2007.
- Oriel JD. Natural history of genital warts. Br J Vener Dis 1971;47:1-13.
- Castellsague X, Drudis T, Canadas MP, Gonce A, Ros R, Perez JM, et al. Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis 2009;9:74.
- Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. Perinatal transmission of human papilomavirus DNA. Virol J 2009;6:83.
- De Vries HJC, Van Doornum GJJ, Bax CJ. Multidisciplinaire Richtlijn Seksueel Overdraagbare Aandoeningen voor de 2e Lijn (2013). NVDV.
- Baumann L, Cina M, Egli-Gany D, Goutaki M, Halsbeisen FS, Lohrer GR, et al. Prevalence of mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect 2018;94:254-61.
- Sonnenberg P, Ison CA, Clifton S, Field N, Tanton C, Soldan K, et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int J Epidemiol 2015;44:1982-94.
- Nijhuis RHT, Duinsbergen RG, Pol A, Godschalk PCR. Prevalence of chlamydia trachomatis, neisseria gonorrhoeae, mycoplasma genitalium and trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands. Eur J Clin Microbiol Infect Dis 2021;40:591-95.
- De Jong AS, Rahamat-Langendoen JC, Van Alphen P, Hilt N, Van Herk C, Pont S, et al. Large two-centre study into the prevalence of mycoplasma genitalium and trichomonas vaginalis in the Netherlands. Int J STD AIDS 2016;27:856-60.
- Martens L, Kuster S, De Vos W, Kersten M, Berkhout H, Hagen F. Macrolide-resistant mycoplasma genitalium in Southeastern region of the Netherlands, 2014-2017. Emerg Infect Dis 2019;25:1297-1303.
- Hetem DJ, Kuizenga Wessel S, Bruisten SM, Braam JF, Van Rooijen MS, et al. High prevalence and resistance rates of mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in the Netherlands. International Journal of STD & AIDS 2021;32:837-44.
- Horner PJ, Martin DH. Mycoplasma genitalium infection in men. J Infect Dis 2017;216:S396-S405.
- Cina M, Baumann L, Egli-Gany D, Halbeisen FS, Ali H, Scott P, et al. Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis. Sex Transm Infect 2019;95:328-35.
- Anagrius C, Loré B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission Sex Transm Infect 2005;81:458-62.
- Falk L, Fredlund H, Jensen JS. Symptomatic urethritis is more prevalent in men infected with mycoplasma genitalium than with Chlamydia trachomatis. Sex Transm Infect 2004;80:289-93.
- Tully JG, Cole RM, Taylor-Robinson D, Rose DL. A newly discovered mycoplasma in the human urogenital tract. The Lancet 1981;317:1288-91.
- Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24:498–514.
- Van der Veer C, Van Rooijen MS, Himschoot M, De Vries HJ, Bruisten SM. Trichomonas vaginalis and mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, the Netherlands. Sex Transm Infect 2016;92:83-5.
- Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 2015;61:418-26.
- De Vries HJC, Nori AV, Kiellberg Larsen H, Kreuter A, Padovese V, Pallawela S, et al. European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. J Eur Acad Dermatol Venereol 2021;35:1434-43.
- Ma C, Du J, Dou Y, Chen R, Li Y, Zhao L, et al. The associations of genital mycoplasmas with female infertility and adverse pregnancy outcomes: a systematic Review and meta-analysis. Reprod Sci 2021;28:3013-31.
- Tantengco OAG, De Castro Silva M, Velayo CL. The role of genital mycoplasma infection in female infertility: a systematic review and meta-analysis. Am J Reprod Immunol 2021;85:e13390.
- Farsimadan M, Motamedifar M. Bacterial infection of the male reproductive system causing infertility. J Reprod Immunol 2020;142:103183.
- Peipert JF, Zhao Q, Schreiber CA, Teal S, Turok DK, Natavio M, et al. Intrauterine device use, sexually transmitted infections, and fertility: a prospective cohort study. Am J Obstet Gynecol 2021;225:157.
- Ahmadi MH, Mirsalehian A, Gilani MAS, Bahador A, Talebi M. Improvement of semen parameters after antibiotic therapy in asymptomatic infertile men infected with mycoplasma genitalium. Infection 2018;46:31-8.
- Gotz HM, Van Bergen JE, Veldhuijzen IK, Broer J, Hoebe CJ, Steyerberg EW, et al. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect 2005;81:24-30.
- Van Bergen J, Gotz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect 2005;81:17-23.
- Op de Coul EL, Gotz HM, Van Bergen JE, Fennema JS, Hoebe CJ, Koekenbier RH, et al. Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity. Sex Transm Dis 2012;39:97-103.
- Dukers-Muijrers NH, Niekamp AM, Brouwers EE, Hoebe CJ. Older and swinging; need to identify hidden and emerging risk groups at STI clinics. Sex Transm Infect 2010;86:315-7.
- RIVM. GRAS Gonokokken Resistentie tegen Antibiotica Surveillance. Voortgangsrapportage (7) (2011). RIVM. Ga naar bron: RIVM. GRAS Gonokokken Resistentie tegen Antibiotica Surveillance. Voortgangsrapportage (7) (2011). RIVM.
- Van Veen MG, Gotz HM, Van Leeuwen PA, Prins M, Van de Laar MJ. HIV and sexual risk behavior among commercial sex workers in the Netherlands. Arch Sex Behav 2010a;39:714-23.
- Unemo M, Bradshaw CS, Hocking JS, De Vries HJC, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis 2017;17:e235-e279.
- Van Bergen JEAM, Hoenderboom BM, David S, Deug F, Heijne JCM, Van Aar F, et al. Where to go to in chlamydia control? From infection control towards infectious disease control. Sex Transm Infect 2021;97:501-6.
- Hocking JS, Temple-Smith M, Guy R, Donovan B, Braat S, Law M, et al. ACCEPt Consortium. Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial. Lancet 2018;392:1413-22.
- Gotz HM, Van den Broek IV, Hoebe CJ, Brouwers EE, Pars LL, Fennema JS, et al. High yield of reinfections by home-based automatic rescreening of Chlamydia positives in a large-scale register-based screening programme and determinants of repeat infections. Sex Transm Infect 2013;89:63-9.
- De Greeff SC, Schoffelen AF, Verduin CM. NethMap 2020: Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands in 2019/MARAN 2020: monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2019. RIVM 2020.
- Anagrius C, Loré B, Jensen JS. Treatment of mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 2013;8:e61481.
- Van Esch TEM, Van Dijk L, Weesie Y, Korevaar J, Verheij R, Essink R et al. Antibioticagebruik bij luchtweginfecties in de eerste lijn. www.nivel.nl: NIVEL, 2016.
- NCSP. Changes to the national chlamydia screening programme. NCSP (2021). (geraadpleegd april 2022) Ga naar bron: NCSP. Changes to the national chlamydia screening programme. NCSP (2021). (geraadpleegd april 2022)
- USPSTF. Final recommendation statement chlamydia and gonorrhea: screening (2021). (geraadpleegd april 2022) Ga naar bron: USPSTF. Final recommendation statement chlamydia and gonorrhea: screening (2021). (geraadpleegd april 2022)
- CDC. Screening recommendations and considerations referenced in treatment guidelines and original sources. CDC (2021). (geraadpleegd …) Ga naar bron: CDC. Screening recommendations and considerations referenced in treatment guidelines and original sources. CDC (2021). (geraadpleegd …)
- RCOG. Knowledge-area-12-sexual-and-reproductive-health. RCOG (2019). Ga naar bron: RCOG. Knowledge-area-12-sexual-and-reproductive-health. RCOG (2019).
- ASHM. Sexual transmissible infections. Guideline chlamydia. ASHM (2021) (geraadpleegd april 2022) Ga naar bron: ASHM. Sexual transmissible infections. Guideline chlamydia. ASHM (2021) (geraadpleegd april 2022)
- British Association for Sexual Health and HIV. 2007 UK National guideline on the management of nongonococcal urethritis.
- Shahmanesh M, Moi H, Lassau F, Janier M, IUSTI/WHO. 2009 European guideline on the management of male non-gonococcal urethritis. Int J STD AIDS. 2009;20:458-64.
- Vriend HJ, Koedijk FDH, Van den Broek IVF, Van Veen MG, Op de Coul ELM, Van Sighem AI, et al. Sexually transmitted infections, including HIV, in the Netherlands in 2009 (2010). Bilthoven: National Institute for Public Health and the Environment, 2010.
- Grillo-Ardila CF, Torres M, Gaitán HG. Rapid point of care test for detecting urogenital chlamydia trachomatis infection in nonpregnant women and men at reproductive age. Cochrane Database Syst Rev 2020:CD011708.
- Garrett N, Mitchev N, Osman F, Naidoo J, Dorward J, Singh R, et al. Diagnostic accuracy of the Xpert CT/NG and OSOM trichomonas rapid assays for point-of-care STI testing among young women in South Africa: a cross-sectional study. BMJ Open 2019;9:e026888.
- Harding-Esch EM, Fuller SS, Chow SC, Nori AV, Harrison MA, Parker M, et al. Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation. Clin Microbiol Infect 2019;25:380.
- Van der Pol B, Taylor SN, Mena L, Lebed J, McNeil CJ, Crane L, et al. Evaluation of the performance of a point-of-care test for chlamydia and gonorrhea. JAMA Netw Open 2020;3:e204819.
- Zhou Y, Jiang TT, Li J, Yin YP, Chen XS. Performance of point-of-care tests for the detection of chlamydia trachomatis infections: a systematic review and meta-analysis. E Clinical Medicine 2021;37:100961.
- Xie TA, Liu YL, Meng RC, Liu XS, Fang KY, Deng ST, et al. Evaluation of the diagnostic efficacy of Xpert CT/NG for chlamydia trachomatis and neisseria gonorrhoeae. Biomed Res Int 2020:2892734.
- Morris SR, Bristow CC, Wierzbicki MR, Sarno M, Asbel L, French A, et al. Performance of a single-use, rapid, point-of-care PCR device for the detection of neisseria gonorrhoeae, chlamydia trachomatis, and trichomonas vaginalis: a cross-sectional study. Lancet Infect Dis 2021;21:668-76.
- Han Y, Shi MQ, Jiang QP, Le WJ, Qin XL, Xiong HZ, et al. Clinical performance of the Xpert® CT/NG test for detection of chlamydia trachomatis and neisseria gonorrhoeae: a multicenter evaluation in Chinese urban hospitals. Front Cell Infect Microbiol 2022;11:784610.
- Blake DR, Maldeis N, Barnes MR, Hardick A, Quinn TC, Gaydos CA. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 2008;35:649-55.
- Schachter J, McCormack WM, Chernesky MA, Martin DH, Van der Pol B, Rice PA, et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 2003;41:3784-9.
- Schachter J, Chernesky MA, Willis DE, Fine PM, Martin DH, Fuller D, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005;32:725-8.
- Schoeman SA, Stewart CM, Booth RA, Smith SD, Wilcox MH, Wilson JD. Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ 2012;345:e8013.
- Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-25.
- Falk L, Coble BI, Mjornberg PA, Fredlund H. Sampling for Chlamydia trachomatis infection - a comparison of vaginal, first-catch urine, combined vaginal and first-catch urine and endocervical sampling. Int J STD AIDS 2010;21:283-7.
- Fang J, Husman C, DeSilva L, Chang R, Peralta L. Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent females. J Pediatr Adolesc Gynecol 2008;21:355-60.
- Geisler WM. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 2011;53 Suppl 3:S92-S98.
- Van der Pol B, Ferrero DV, Buck-Barrington L, Hook E, III, Lenderman C, Quinn T, et al. Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol 2001;39:1008-16.
- RIVM. Redactie Infectieziekten Bulletin. Wanneer kun je na onbeschermde seks testen op chlamydia en gonorroe/IB 10-2014 (2014). (geraadpleegd mei 2022). Ga naar bron: RIVM. Redactie Infectieziekten Bulletin. Wanneer kun je na onbeschermde seks testen op chlamydia en gonorroe/IB 10-2014 (2014). (geraadpleegd mei 2022).
- Henquet CJ, De Vries RR. Problemen bij de interpretatie van serologische uitslagen van syfilis. Ned Tijdschr Geneeskd 1994;138:1705-8.
- Bruisten SM, Cairo I, Fennema H, Pijl A, Buimer M, Peerbooms PG, et al. Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands. J Clin Microbiol 2001;39:601-5.
- Delaney KP, Hanson DL, Masciotra S, Ethridge SF, Wesolowski L, Owen SM. Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure. Clin Infect Dis 2017;64:53-9.
- Brum MCB, Filho FFD, Yates ZB, Viana MCV, Chaves EBM, Trindade DM. HIV seroconversion in a health care worker who underwent postexposure prophylaxis following needlestick injury. Am J Infect Control 2013;41:471-2.
- Terzi R, Niero F, Lemoli E, Capetti A, Coen M, Rizzardini G. Late HIV seroconversion after non-occupational postexposure prophylaxis against HIV with concomitant hepatitis C virus seroconversion. AIDS 2007;21:262-3.
- Tan WS, Chow EP, Fairley CK, Chen MY, Bradshaw CS, Read TR. Sensitivity of HIV rapid tests compared with fourth-generation enzyme immunoassays or HIV RNA tests. AIDS 2016;30:1951-60.
- Van Tienen C, Rugebregt S, Scherbeijn S, Götz H, Geurts van Kessel C. The performance of the Alere HIV combo point-of-care test on stored serum samples; useful for detection of early HIV-1 infections? Sex Transm Infect 2018;94:331-3.
- Meulbroek M, Pujol F, Pérez F, Dalmau-Bueno A, Taboada H, Marazzi G, Carrillo A, et al. BCN checkpoint: same-day confirmation of reactive HIV rapid test with point of care HIV-RNA accelerates linkage to care and reduces anxiety. HIV Med 2018;19:63-5.
- Stafylis C, Klausner JD. Evaluation of two 4th generation point-of-care assays for the detection of human immunodeficiency virus infection. PLoS One 2017;12:e0183944.
- Fitzgerald N, Cross M, O'Shea S, Fox J. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24. Sex Transm Infect 2017;93:100-101.
- Stekler JD, Ure G, O'Neal JD, Lane A, Swanson F, Maenza J, et al. Performance of determine combo and other point-of-care HIV tests among Seattle MSM. J Clin Virol 2016;76:8-13.
- Peters PJ, Westheimer E, Cohen S, Hightow-Weidman LB, Moss N, Tsoi B, et al. Screening yield of HIV antigen/antibody combination and pooled HIV RNA testing for acute HIV infection in a high-prevalence population. JAMA 2016;315:682-90.
- Allan-Blitz LT, Vargas SK, Konda KA, Herbst de Cortina S, Cáceres CF, et al. Field evaluation of a smartphone-based electronic reader of rapid dual HIV and syphilis point-of-care immunoassays. Sex Transm Infect 2018;94:589-93.
- Black V, Williams BG, Maseko V, Radebe F, Rees HV, Lewis DA. Field evaluation of standard diagnostics' bioline HIV/syphilis duo test among female sex workers in Johannesburg, South Africa. Sex Transm Infect 2016;92:495-8.
- Dare-Smith R, Badrick T, Cunningham P, Kesson A, Badman S. Quality assuring HIV point of care testing using whole blood samples. Pathology 2016;48:498-500.
- Meggi B, Bollinger T, Mabunda N, Vubil A, Tobaiwa O, Quevedo JI, et al. Point-Of-Care p24 infant testing for HIV may increase patient identification despite low sensitivity. PLoS One 2017;12:e0169497.
- Ran B, Xianyu Y, Dong M, Chen Y, Qian Z, Jiang X. Bioorthogonal reaction-mediated ELISA using peroxide test strip as signal readout for point-of-care testing. Anal Chem 2017;89:6113-9.
- Sutcliffe CG, Mutanga J, Moyo N, Agarwal AK, Schue JL, Hamahuwa M, et al. Point-of-care p24 antigen detection for early infant diagnosis of HIV infection: cross-sectional and longitudinal studies in Zambia. BMC Infect Dis 2021;21:118.
- van Sighem AI, Wit FWNM, Boyd A, Smit C, Matser A, Reiss P. Monitoring Report 2019. Human Immunodeficiency Virus (HIV) Infection in the Netherlands. Amsterdam: Stichting HIV Monitoring, 2020.
- Schwebke JR, Lawing LF. Improved detection by DNA amplification of Trichomonas vaginalis in males. J Clin Microbiol 2002;40:3681-3.
- Radonjic IV, Dzamic AM, Mitrovic SM, rsic Arsenijevic VS, Popadic DM, Kranjcic Z, I. Diagnosis of Trichomonas vaginalis infection: The sensitivities and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol Reprod Biol 2006;126:116-20.
- Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002;35:576-80.
- Madico G, Quinn TC, Rompalo A, McKee KT, Jr., Gaydos CA. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998;36:3205-10.
- Lawing LF, Hedges SR, Schwebke JR. Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J Clin Microbiol 2000;38:3585-8.
- Gezondheidsraad. Preventief gebruik van hiv-remmers. Den Haag: Gezondheidsraad, 2018; publicatienr. 2018/06. (geraadpleegd november 2021) Ga naar bron: Gezondheidsraad. Preventief gebruik van hiv-remmers. Den Haag: Gezondheidsraad, 2018; publicatienr. 2018/06. (geraadpleegd november 2021)
- Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. iPrEx Study Team. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 2012;4:151ra125.
- Ab E, Luijt D, Ott A, Dekker JH. High rates of anorectal chlamydia in women: a cross-sectional study in general practice. BJGP Open 2022:BJGPO.2021.0223.
- Páez-Canro C, Alzate JP, González LM, Rubio-Romero JA, Lethaby A, Gaitán HG. Antibiotics for treating urogenital chlamydia trachomatis infection in men and non-pregnant women. Cochrane Database Syst Rev 2019:CD010871.
- Khosropour CM, Bell TR, Hughes JP, Manhart LE, Golden MR. A population-based study to compare treatment outcomes among women with urogenital chlamydial infection in Washington State, 1992 to 2015. Sex Transm Dis 2018;45:319-24.
- Dukers-Muijrers NH, Van Liere GA, Hoebe CJ. Re-screening chlamydia trachomatis positive subjects: a comparison of practices between an STI clinic, general practitioners and gynaecologists. Sex Transm Infect 2013;89:25-7.
- Kong FY, Tabrizi SN, Fairley CK, Vodstrcil LA, Huston WM, Chen M, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. J Antimicrob Chemother 2015;70:1290-7.
- Gratrix J, Brandley J, Dane M, Plitt SS, Smyczek P, Read R, et al. A retrospective review of treatment failures using azithromycin and doxycycline in the treatment of rectal chlamydia infections in women and men who have sex with men. Sex Transm Dis 2016;43:110-2.
- Dombrowski JC, Wierzbicki MR, Newman LM, Powell JA, Miller A, Dithmer D, et al. Doxycycline versus azithromycin for the treatment of rectal chlamydia in men who have sex with men: a randomized controlled trial. Clin Infect Dis 2021;73:824-31.
- Kang-Birken SL. Challenges in treating chlamydia trachomatis, including rectal infections: Is it time to go back to doxycycline? Ann Pharmacother 2022;56:330-8.
- Chen LF, Wang TC, Chen FL, Hsu SC, Hsu CW, Bai CH, Hsu YP. Efficacy of doxycycline versus azithromycin for the treatment of rectal chlamydia: a systematic review and meta-analysis. J Antimicrob Chemother. 2021;76:3103-10.
- Lau A, Kong FYS, Fairley CK, Templeton DJ, Amin J, Phillips S, et al. Azithromycin or doxycycline for asymptomatic rectal chlamydia trachomatis. N Engl J Med 2021;384:2418-27.
- Van Liere GA, Hoebe CJ, Wolffs PF, Dukers-Muijrers NH. High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study: a recommendation towards a better anorectal chlamydia control in women. BMC Infect Dis 2014;14:274.
- Craig AP, Kong FY, Yeruva L, Hocking JS, Rank RG, Wilson DP, et al. Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract. BMC Infect Dis 2015;15:200.
- Batteiger BE. Azithromycin efficacy in asymptomatic rectal chlamydial infection in men who have sex with men: a more definitive answer soon? Sex Transm Dis 2017;44:403-5.
- Peuchant O, Lhomme E, Krêt M, Ghezzoul B, Roussillon C, Bébéar C, et al, and the Chlazidoxy study group. Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal chlamydia trachomatis infection concomitant to a vaginal infection (CHLAZIDOXY study). Medicine (Baltimore) 2019;98:e14572.
- Fan H, Gilbert R, O'Callaghan F, Li L. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. BMJ 2020;368:m331.
- Cluver C, Novikova N, Eriksson DO, Bengtsson K, Lingman GK. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev 2017:CD010485.
- Rahangdale L, Guerry S, Bauer HM, Packel L, Rhew M, Baxter R, et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis 2006;33:106-10.
- Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. CMAJ 2017;189:E625-33.
- Batteiger BE, Tu W, Ofner S, Van der Pol B, Stothard DR, Orr DP, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010a;201:42-51.
- Fung M, Scott KC, Kent CK, Klausner JD. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007;83:304-9.
- Heijne JC, Althaus CL, Herzog SA, Kretzschmar M, Low N. The role of reinfection and partner notification in the efficacy of Chlamydia screening programs. J Infect Dis 2011;203:372-7.
- Hosenfeld CB, Workowski KA, Berman S, Zaidi A, Dyson J, Mosure D, et al. Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009;36:478-89.
- Scott LD, Baster K, Emmett L, Nichols T, Randall S, McLean L, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect 2007;83:292-303.
- Veldhuijzen IK, Van Bergen JE, Gotz HM, Hoebe CJ, Morre SA, Richardus JH. Reinfections, persistent infections, and new infections after general population screening for Chlamydia trachomatis infection in the Netherlands. Sex Transm Dis 2005;32:599-604.
- Van Valkengoed IG, Morre SA, Van den Brule AJ, Meijer CJ, Bouter LM, Van Eijk JT, et al. Partner notification among asymptomatic Chlamydia trachomatis cases, by means of mailed specimens. Br J Gen Pract 2002;52:652-4.
- Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 2010;15.
- Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011;16.
- Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011;55:3538-45.
- Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis 2007;57:13S-8S.
- Brocklehurst P. Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev 2002;CD000098.
- SeksHAG. Hiv – verdieping naast de NHG -Standaard ‘Het Soa -Consult’. 2019. (geraadpleegd november 2021) Ga naar bron: SeksHAG. Hiv – verdieping naast de NHG -Standaard ‘Het Soa -Consult’. 2019. (geraadpleegd november 2021)
- Lara-Torre E, Pinkerton JS. Accuracy of detection of trichomonas vaginalis organisms on a liquid-based papanicolaou smear. Am J Obstet Gynecol 2003;188:354-6.
- Loo SK, Tang WY, Lo KK. Clinical significance of Trichomonas vaginalis detected in Papanicolaou smear: a survey in female Social Hygiene Clinic. Hong Kong Med J 2009;15:90-3.
- Forna F, Gülmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2003;CD000218.
- Beard CM, Noller KL, O’Fallon WM, Kurland LT, Dahlin DC. Cancer after exposure to metronidazole. Mayo Clin Proc 1988;63:147-53.
- Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997;44:179-82.
- Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 2001;63:186-92.
- Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995;172:525-9.
- Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998;105:322-7.
- Mylonas I. Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet 2011;283:7-18.
- CVZ. Farmacotherapeutisch Kompas (2012).
- Schaefer C, Peters P, Miller RK. Drugs during pregnancy and lactation. Treatment options and risk assessment. 2e dr. Amsterdam: Elsevier BV, 2007.
- Abudalu M, Tyring S, Koltun W, Bodsworth N, Hamed K. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial. Clin Infect Dis 2008;47:651-8.
- Chosidow O, Drouault Y, Leconte-Veyriac F, Aymard M, Ortonne JP, Pouget F, et al. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial. Br J Dermatol 2001;144:818-24.
- Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis 1997;24:481-6.
- Saiag P, Praindhui D, Chastang C. A double-blind, randomized study assessing the equivalence of valacyclovir 1000 mg once daily versus 500 mg twice daily in the episodic treatment of recurrent genital herpes. Genival Study Group. J Antimicrob Chemother 1999;44:525-31.
- Tyring SK, Edwards L, Cherry LK, Ramsdell WM, Kotner S, Greenberg MD, et al. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts. Arch Dermatol 1998b;134:33-8.
- Clinical Effectiveness Group. 2007 UK national guideline on the management of non-gonococcal urethritis. London (UK): British Association for Sexual Health and HIV (BASHH); 2008.
- Patel R, Alderson S, Geretti A, Nilsen A, Foley E, Lautenschlager S, et al. European guideline for the management of genital herpes, 2010. Int J STD AIDS 2011;22:1-10.
- Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110.
- Lebrun-Vignes B, Bouzamondo A, Dupuy A, Guillaume JC, Lechat P, Chosidow O. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks. J Am Acad Dermatol 2007;57:238-46.
- Mertz GJ, Critchlow CW, Benedetti J, Reichman RC, Dolin R, Connor J, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984;252:1147-51.
- Sacks SL, Aoki FY, Martel AY, Shafran SD, Lassonde M. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial. Clin Infect Dis 2005;41:1097-104.
- Spruance SL, Tyring SK, Degregorio B, Miller C, Beutner K. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Arch Intern Med 1996;156:1729-35.
- Tyring SK, Douglas JM, Jr., Corey L, Spruance SL, Esmann J. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Arch Dermatol 1998a;134:185-91.
- Lacey CJ, Woodhall SC, Wikstrom A, Ross J. 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol 2012 [Epub ahead of print].
- Tatti S, Stockfleth E, Beutner KR, Tawfik H, Elsasser U, Weyrauch P, et al. Polyphenon E: a new treatment for external anogenital warts. Br J Dermatol 2010;162:176-84.
- CVZ. GVS-rapport 13/03 sinecatechineszalf (Veregen®) (2013).
- Anonymus. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-27.
- Ault KA. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007;369:1861-8.
- Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-43.
- Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsague X, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012;13:89-99.
- Munoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 2010;102:325-39.
- Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007;369:2161-70.
- Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-14.
- Munoz N, Manalastas R, Jr., Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 2009;373:1949-57.
- Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 2012;344:e1401.
- Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007;196:1447-54.
- Boot HJ. Objectieve registratie en interpretatie van vaccinbijwerkingen: een essentieel element van vaccinatie. Ned Tijdschr Geneeskd 2007;151:2707-8.
- Bradshaw CS, Tabrizi SN, Read TR, Garland SM, Hopkins CA, Moss LM, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006;193:336-45.
- Machalek DA, Tao Y, Shilling H, Jensen JS, Unemo M, Murray G, et al. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in mycoplasma genitalium: a systematic review and meta-analysis. Lancet Infect Dis 2020;20:1302-14.
- Braam JF, Hetem DJ, Vergunst CE, Kuizenga Wessel S, Van Rooijen MS, Nijhuis RHT, et al. Evaluating the prevalence and risk factors for macrolide resistance in mycoplasma genitalium using a newly developed qPCR assay. PLoS One 2020;15:e0240836.
- Romano SS, Jensen JS, Lowens MS, Morgan JL, Chambers LC, Robinson TS, et al. Long duration of asymptomatic mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis. Clin Infect Dis 2019;69:113-20.
- Fifer H, Merrick R, Pitt R, Yung M, Allen H, Day M, et al. MARS Collaborators Group. Frequency and correlates of mycoplasma genitalium antimicrobial resistance mutations and their association with treatment outcomes: findings from a national sentinel surveillance pilot in England. Sex Transm Dis 2021;48:951-4.
- Van Dam AP. Antibiotische behandeling van Mycoplasma genitalium bij urethritis. TIJDSCHR INFECT 2018;13(6):214-5
- Bradshaw CS, Jensen JS, Waites KB. New horizons in mycoplasma genitalium treatment. J Infect Dis 2017;216(suppl_2):S412-19.
- Gesink D, Racey CS, Seah C, Zittermann S, Mitterni L, Juzkiw J, et al.Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance. Can Fam Physician 2016;62:e96-101.
- PHAC. Sexually transmitted and blood-borne infection guides. The Public Health Agency of Canada (2022). (geraadpleegd april 2022) Ga naar bron: PHAC. Sexually transmitted and blood-borne infection guides. The Public Health Agency of Canada (2022). (geraadpleegd april 2022)